European Journal of Clinical Medicine, vol.2, no.1, pp.13-14, 2021 (Refereed Journals of Other Institutions)
The COVID-19 pandemic affects all age groups but follows a more mortal
trajectory in patients with preexisting conditions such as immune
deficiency, chronic lung disease, diabetes, and cardiovascular problems.
Hence, HIV-positive patients with immune deficiency are at risk,
therefore, these patients need to have continuous access to treatment
during the pandemic. The number of defined COVID-19 positive HIV
patients is very limited even though there are approximately 37.9 million
HIV-positive patients globally. Therefore, we decided to publish this study
reporting an HIV patient treated for COVID-19 in our clinic.